Annexins as Neuroprotective Agents in the Central Nervous System
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
87-107
Author(s):
Joanna Bandorowicz-Pikula
Use of the Bradykinin Agonist, Cereport as a Pharmacological Means of Increasing Drug Delivery to the CNS
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
109-123
Author(s):
Dwaine F. Emerich
Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
135-161
Author(s):
S. Rahbar and J.L. Figarola
Preface
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
i-i
Author(s):
Sandor Solyom and Istvan Tarnawa
Amino-Alkyl-Cyclohexanes as a Novel Class of Uncompetitive NMDA Receptor Antagonists
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
835-843
Author(s):
W. Danysz, C. G. Parsons, A. Jirgensons, V. Kauss and J. Tillner
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Physiology of Folic Acid in Health and Disease
Journal:
Current Drug Metabolism
Volume:
3
Page:
211-223
Author(s):
O. Stanger
Hyperhomocysteinemia, Pteridines and Oxidative Stress
Journal:
Current Drug Metabolism
Volume:
3
Page:
225-232
Author(s):
B. Widner, C. Enzinger, A. Laich, B. Wirleitner and D. Fuchs
Preface
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
i-i
Author(s):
C. A. Tamminga and Joseph T. Coyle
Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
141-147
Author(s):
C. A. Tamminga and A. Carlsson